These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 4655986)
1. [New views on the pathophysiology of disseminated sclerosis]. Cendrowski W Neurol Neurochir Pol; 1972; 6(5):817-21. PubMed ID: 4655986 [No Abstract] [Full Text] [Related]
2. Pathophysiology of multiple sclerosis and related clinical implications. Davis FA Mod Treat; 1970 Sep; 7(5):890-902. PubMed ID: 4933354 [No Abstract] [Full Text] [Related]
3. [Change in the acid-base equilibrium and its interrelationship to sodium-potassium metabolism in adaptation to multiple discontinuous heat effects]. Afanas'ev BG Gig Sanit; 1973 Feb; 38(2):110-3. PubMed ID: 4779866 [No Abstract] [Full Text] [Related]
7. [Etiopathogenesis of multiple sclerosis in the light of current studies]. Strelau K Neurol Neurochir Pol; 1972; 6(1):93-8. PubMed ID: 4553032 [No Abstract] [Full Text] [Related]
8. Renal regulation of acid-base balance. Rector FC Aust N Z J Med; 1981; 11(Suppl 1):1-5. PubMed ID: 6789807 [No Abstract] [Full Text] [Related]
9. Complexity and heterogeneity in demyelinating disease. Compston A Brain; 2007 May; 130(Pt 5):1178-80. PubMed ID: 17472981 [No Abstract] [Full Text] [Related]
10. Approaches to the development of pharmacological interventions in multiple sclerosis. Davis FA; Schauf CL Adv Neurol; 1981; 31():505-10. PubMed ID: 6275674 [No Abstract] [Full Text] [Related]
11. Pathophysiology of demyelinating disease. Halliday AM; McDonald WI Br Med Bull; 1977 Jan; 33(1):21-7. PubMed ID: 318885 [No Abstract] [Full Text] [Related]
12. Membranes, myelin, and the pathophysiology of multiple sclerosis. Waxman SG N Engl J Med; 1982 Jun; 306(25):1529-33. PubMed ID: 7043271 [No Abstract] [Full Text] [Related]
15. Uhthoff's phenomenon as the first manifestation of multiple sclerosis in an adult male. Santos-Bueso E; Viera-Peláez D; Asorey-García A; Porta-Etessam J; Vinuesa-Silva JM; García-Sánchez J J Fr Ophtalmol; 2016 May; 39(5):e123-4. PubMed ID: 26949115 [No Abstract] [Full Text] [Related]
16. Ionic permeability changes in active axon membranes. Hille B Arch Intern Med; 1972 Feb; 129(2):293-8. PubMed ID: 5058552 [No Abstract] [Full Text] [Related]
17. [Mechanisms of lability of neurological symptoms in multiple sclerosis]. Peresedova AV; Baĭdina EV; Trifonova OV; Aĭzenberg IV; Gnezditskiĭ VV; Barkhatova VP; Chernikova LA; Zavalishin IA Zh Nevrol Psikhiatr Im S S Korsakova; 2002; Suppl():15-9. PubMed ID: 12418387 [TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of delayed evoked potentials in multiple sclerosis. Onofrj M; Bazzano S; Malatesta G; Gambi D Funct Neurol; 1990; 5(4):301-19. PubMed ID: 2093049 [No Abstract] [Full Text] [Related]
19. The pathophysiology of demyelination and the ionic basis of nerve conduction in multiple sclerosis: an overview. Boyden KM J Neurosci Nurs; 2000 Feb; 32(1):49-53, 60. PubMed ID: 10955274 [TBL] [Abstract][Full Text] [Related]
20. Some spaces and barriers in postmortem multiple sclerosis. Tourtellotte WW; Parker JA Prog Brain Res; 1968; 29():493-525. PubMed ID: 5735306 [No Abstract] [Full Text] [Related] [Next] [New Search]